José Sanz Moreno

Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

Belén Gutiérrez‐Gutiérrez, Alberto M. Borobia, Antonio J. Carcas et al. · The Lancet Infectious Diseases · 2021 · 102 citations · Full text

Medicine, Clinical Sciences, Infectious Diseases +13

Changes in the immune response against SARS-CoV-2 in individuals with severe COVID-19 treated with high dose of vitamin D

Montserrat Torres, Guiomar Casado, Lorena Vigón et al. · Biomedicine & Pharmacotherapy · 2022 · 44 citations · Full text

Medicine, Immunology, Infectious Diseases +17

Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials

Chloe Orkin, Jean‐Michel Molina, Pedro Cahn et al. · The Lancet HIV · 2023 · 32 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

A Predictive Model and Risk Factors for Case Fatality of COVID-19

Melchor Álvarez‐Mon, Miguel Á. Ortega, Óscar Gasulla et al. · Journal of Personalized Medicine · 2021 · 29 citations · Full text

Medicine, Health Sciences, Infectious Diseases +15

Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015

José Antonio Iribarren, Rafael Rubio, Koldo Aguirrebengoa et al. · Enfermedades Infecciosas y Microbiología Clínica · 2016 · 18 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17